Sentinal4D is developing personalised therapeutics treatments to help treat patients battling cancer, neurodegenerative diseases, and chronic inflammatory syndromes. They are deploying a biology-first, holistic approach with focus on phenotypic-based drug discovery. By harnessing AI-powered 3D cell imaging, they are transforming drug discovery and development, accelerating the journey of groundbreaking treatments from lab to clinic.